Alfasigma announces that Zelnorm now available in the U.S. to treat IBS in adult women
BEDMINSTER, N.J. — Alfasigma USA announced Friday that Zelnorm (tegaserod) is now available in the United States as a prescription pharmaceutical treatment for irritable bowel syndrome with constipation (IBS-C) in adult women less than 65 years of age. Alfasigma USA acquired Zelnorm from Sloan Pharma S.à r.l., a subsidiary of US WorldMeds Holdings, in July
